The Oaktree platform brings best-in-class sourcing and the broad investing capabilities necessary for a successful SPAC transaction.

SPAC Vehicles

11 Dec 2024	Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 16, 2024
23 Oct 2024	Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering
15 Jun 2022	Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16
06 Jun 2022	Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination

If you are interested in partnering with Oaktree, please contact us at: info@oaktreeacquisitioncorp.com